Dexedrine

Narcolepsy, Attention Deficit Hyperactivity Disorder

Treatment

2 FDA approvals

20 Active Studies for Dexedrine

What is Dexedrine

Dextroamphetamine

The Generic name of this drug

Treatment Summary

Dextroamphetamine is a medication used to treat attention deficit hyperactivity disorder (ADHD). It is a type of amphetamine that has been approved by the FDA since 2001.

Dextrostat

is the brand name

image of different drug pills on a surface

Dexedrine Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Dextrostat

Dextroamphetamine

1975

569

Approved as Treatment by the FDA

Dextroamphetamine, also known as Dextrostat, is approved by the FDA for 2 uses such as Narcolepsy and Attention Deficit Hyperactivity Disorder .

Narcolepsy

Helps manage Narcolepsy

Attention Deficit Hyperactivity Disorder

Used to treat Attention Deficit Hyperactivity Disorder (ADHD) in combination with Amphetamine

Effectiveness

How Dexedrine Affects Patients

Dextroamphetamine is a drug that stimulates the central nervous system and increases blood pressure, improves breathing, and can act as a mild bronchodilator. The exact way it works is not yet known.

How Dexedrine works in the body

The exact way that amphetamines work is not known. Dextroamphetamine, however, is known to increase the amount of dopamine in the brain. It does this by blocking the reuptake of dopamine, increasing its release, and stimulating the backward transport of dopamine from synapses in the brain. Recent research suggests that amphetamines may also affect the number of dopamine transporters in the brain.

When to interrupt dosage

The proposed dosage of Dexedrine is contingent upon the recognized condition. The amount additionally fluctuates as per the strategy of administration (e.g. Tablet or Oral) featured in the table beneath.

Condition

Dosage

Administration

Narcolepsy

, 5.0 mg, 10.0 mg, 15.0 mg, 5.0 mg/mL, 2.5 mg, 7.5 mg, 20.0 mg, 30.0 mg, 3.125 mg, 6.25 mg, 9.375 mg, 12.5 mg, 1.875 mg, 1.25 mg, 3.75 mg, 25.0 mg, 18.75 mg, 60.0 mg, 40.0 mg

, Oral, Capsule, extended release, Capsule, extended release - Oral, Liquid - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral

Attention Deficit Hyperactivity Disorder

, 5.0 mg, 10.0 mg, 15.0 mg, 5.0 mg/mL, 2.5 mg, 7.5 mg, 20.0 mg, 30.0 mg, 3.125 mg, 6.25 mg, 9.375 mg, 12.5 mg, 1.875 mg, 1.25 mg, 3.75 mg, 25.0 mg, 18.75 mg, 60.0 mg, 40.0 mg

, Oral, Capsule, extended release, Capsule, extended release - Oral, Liquid - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral

Warnings

Dexedrine Contraindications

Condition

Risk Level

Notes

Hypertensive disease

Do Not Combine

Drug abuse

Do Not Combine

Pulse Frequency

Do Not Combine

Open-angle glaucoma

Do Not Combine

symptomatic cardiovascular disease

Do Not Combine

advanced arteriosclerosis

Do Not Combine

Hyperthyroidism

Do Not Combine

Agitation

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Dextroamphetamine may interact with Pulse Frequency

There are 20 known major drug interactions with Dexedrine.

Common Dexedrine Drug Interactions

Drug Name

Risk Level

Description

Clonidine

Major

The metabolism of Clonidine can be decreased when combined with Dextroamphetamine.

Dacomitinib

Major

The metabolism of Dacomitinib can be decreased when combined with Dextroamphetamine.

Enasidenib

Major

The metabolism of Enasidenib can be decreased when combined with Dextroamphetamine.

Erlotinib

Major

The metabolism of Erlotinib can be decreased when combined with Dextroamphetamine.

Flecainide

Major

The metabolism of Flecainide can be decreased when combined with Dextroamphetamine.

Dexedrine Toxicity & Overdose Risk

Research in mice has shown that taking dextroamphetamine in large doses can lead to bone deformities, breathing and digestive issues, and low birth weight in babies. Human studies have not been done, so the risk versus benefit of taking the drug while pregnant should be carefully considered. Mothers should avoid taking dextroamphetamine while breastfeeding, as the drug passes into breast milk. The long-term effects of this drug in young children are not known, so it is best to avoid giving dextroamphetamine to children under 3 years old.

image of a doctor in a lab doing drug, clinical research

Dexedrine Novel Uses: Which Conditions Have a Clinical Trial Featuring Dexedrine?

84 active clinical trials are investigating the potential of Dexedrine for treating conditions like Narcolepsy.

Condition

Clinical Trials

Trial Phases

Attention Deficit Hyperactivity Disorder

63 Actively Recruiting

Not Applicable, Phase 3, Phase 4, Phase 1, Phase 2

Narcolepsy

2 Actively Recruiting

Not Applicable, Phase 1

Dexedrine Reviews: What are patients saying about Dexedrine?

5

Patient Review

6/19/2012

Dexedrine for Attention Deficit Disorder with Hyperactivity

5

Patient Review

7/28/2013

Dexedrine for Attention Deficit Disorder with Hyperactivity

5

Patient Review

8/30/2013

Dexedrine for Attention Deficit Disorder with Hyperactivity

I lost my wife because she became addicted to my pills. The addiction made her irrational and violent.

5

Patient Review

11/13/2013

Dexedrine for Attention Deficit Disorder with Hyperactivity

It's very difficult to obtain this medication because doctors are unwilling to prescribe it for my schizoaffective disorder. That being said, it's the only medication that works for me and without it I'm a danger to myself and others.

5

Patient Review

1/10/2015

Dexedrine for Attention Deficit Disorder with Hyperactivity

When all other treatments failed, this one really saved me. I'm so grateful to be alive and well today.

5

Patient Review

4/9/2021

Dexedrine for Attention Deficit Disorder with Hyperactivity

My son took this from age 7 to high school and it was a game-changer. He was able to focus and think before acting, which made life much easier for him. I only wish he had chosen to continue taking it into adulthood.

4.7

Patient Review

2/25/2014

Dexedrine for Attention Deficit Disorder with Hyperactivity

I'm curious if anyone else takes 30mg twice a day. That's what my doctor prescribed for me and it seems to be working well, but I want to make sure that's a normal dosage.

4.3

Patient Review

9/2/2019

Dexedrine for Attention Deficit Disorder with Hyperactivity

This drug has been really helpful for me while studying. It's a shame that it took so long for me to be prescribed this medication.

4.3

Patient Review

10/6/2021

Dexedrine for Attention Deficit Disorder with Hyperactivity

This medication has been a total game-changer for me. I no longer feel like I'm in a fog all the time and can actually get up and do what needs to be done. My thoughts are clear and concise for the first time ever.Side effects: rapid HR, sweating, sleep issues if taken late in the day and loss of appetite, but mostly all is under control.

4.3

Patient Review

2/6/2021

Dexedrine for Attention Deficit Disorder with Hyperactivity

This medication has helped me a lot with my ADHD. I've seen significant improvements in my focus, memory, impulse control, and mood and energy regulation.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about dexedrine

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Dexedrine a narcotic?

"DEXEDRINE is classified as a CII drug by the federal government because it has a potential for abuse and can lead to dependence. Keep DEXEDRINE in a safe place to prevent misuse and abuse."

Answered by AI

Do they still prescribe Dexedrine?

"Although Dexedrine is still prescribed, it is not as popular as newer medications for ADHD such as Adderall, Vyvanse, and Mydayis."

Answered by AI

How does Dexedrine make you feel?

"The strongest component in amphetamine, dextroamphetamine, has a stronger effect than amphetamine, promoting focus and making the person who takes it feel energetic, positive, and euphoric."

Answered by AI

What does Dexedrine do to your body?

"It may also help you to organize your tasks and improve listening skills.

Dextroamphetamine can help improve focus and attention by altering the levels of certain chemicals in the brain. It is classified as a stimulant and can also aid in reducing behavioral problems and improve task organization and listening skills."

Answered by AI

Clinical Trials for Dexedrine

Image of Seattle Children's Hospital in Seattle, United States.

Organizational Skills Training vs Mindfulness for ADHD

13 - 17
All Sexes
Seattle, WA

This randomized control trial comparing Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) among adolescents with a pre-existing ADHD diagnosis presenting to the Duke ADHD Program. Both treatments are eight 90 minute sessions. The research component will involve a pre-treatment assessment and post-treatment assessment. Both assessments will involve adolescents and one caregiver to complete questionnaires over REDCap. Rating scales will include ADHD symptom severity (Conners 3: self and parent report), functional impairment (IRS: self and parent report), executive functioning (BRIEF-2: parent report), emotion dysregulation (DERS: self and parent report), trait mindfulness (FFMQ: self report), organizational skills (BRIEF-2: parent report), treatment satisfaction (self report and parent report) and credibility (self report and parent report). Post-treatment assessments for feasibility will include attendance (measured over the course of treatment) and homework completion rates on a scale of 1 to 5 in which 5 indicates higher homework completion. We will also assess acceptability via individual items on a Likert scale (self report): overall satisfaction, how much was learned about ADHD, usefulness of information learned, content relevance to individual experience, comprehension of strategies, confidence about using strategies, likelihood of using strategies, helpfulness to share with the group, benefits from hearing from other group members, willingness to recommend the same treatment to others, and whether or not treatment was beneficial.

Recruiting
Has No Placebo

Seattle Children's Hospital

Image of St. Jude Children's Research Hospital in Memphis, United States.

Methylphenidate for Sickle Cell Disease

8 - 17
All Sexes
Memphis, TN

The purpose of this study is to determine if patients with sickle cell disease (SCD) can consistently take a drug called Methylphenidate (MPH) daily, once a day for 4 weeks to help with any thinking, attention or schoolwork problems and if they have any side effects. The study will assess any thinking or attention problems participants may have both before taking this drug and after. Additionally, the study will assess the decision-making process of the caregiver that may influence using this drug or not. Primary Objective: • Assess the feasibility, acceptability, and adherence to MPH treatment in children with SCD and EF deficits. Secondary Objective: • Evaluate neurobehavioral and safety outcomes following MPH treatment. Exploratory Objective: • Evaluate decision-making and determinants influencing methylphenidate utilization among parents.

Phase 1
Recruiting

St. Jude Children's Research Hospital

Andrew Heitzer, PhD

Have you considered Dexedrine clinical trials?

We made a collection of clinical trials featuring Dexedrine, we think they might fit your search criteria.
Go to Trials
Image of The University of Iowa in Iowa City, United States.

fMRI for Cognitive Flexibility

18 - 35
All Sexes
Iowa City, IA

The goal of this basic experimental research study is to examine how the human thalamus supports flexible thinking and behavior. Specifically, the research aims to elucidate how the mediodorsal (MD) thalamus encodes and updates "context"-the mental framework that determines which rules or actions are relevant in a given situation. This work may contribute to understanding why certain psychiatric conditions, such as schizophrenia and ADHD, involve difficulties with cognitive flexibility and control. The primary research questions are: Does the MD thalamus represent the context that organizes how working memory guides task selection? Does the MD thalamus signal when context needs to be updated after a change in task demands? Do these thalamic representations support generalization to new situations or rules? Participants will complete cognitive tasks while undergoing high-resolution brain imaging using 7-Tesla MRI. The investigators will combine behavioral data, computational modeling, and advanced neuroimaging analyses to examine how the thalamus interacts with the cortex during flexible decision-making.

Waitlist Available
Has No Placebo

The University of Iowa

Image of UCSF Nancy Friend Pritzker Psychiatry Building in San Francisco, United States.

Trigeminal Nerve Stimulation for ADHD in Children with Autism

7 - 14
All Sexes
San Francisco, CA

The goal of this clinical trial is to learn if external trigeminal nerve stimulation (eTNS) works to treat ADHD symptoms in children on the autism spectrum (ASD). It will also learn about the efficacy and tolerability of the eTNS device. The main questions it aims to answer are: * Does eTNS reduce ADHD symptoms? * Does eTNS improve core and associated features of ASD? Participation spans 8-12 weeks and includes: * 4-5 in-person visits * 4 brief virtual check-ins * Nightly use of the eTNS device with a small sticky patch applied to child's forehead * Randomized assignment (those who start with the sham device may try the active device later)

Recruiting
Device

UCSF Nancy Friend Pritzker Psychiatry Building

Image of The University of Texas at Austin in Austin, United States.

Transcranial Photobiomodulation for ADHD

18 - 44
All Sexes
Austin, TX

The investigators have previously shown that non-invasive methods of brain stimulation such as the administration of transcranial infrared light to the prefrontal cortex (PFC) can result in improvements to cognition and emotion as well as brain oxygenation. This method is called transcranial photobiomodulation (tPBM). The investigators hypothesize that tPBM can improve cognition and brain oxygenation in adults with attention deficit hyperactivity disorder (ADHD). The investigators will investigate the effects of repeated tPBM sessions on cognitive functioning in adults with ADHD. Specifically, the investigators hypothesize that participants that receive tPBM will show improvements in response control, sustained attention, and working memory, as well as improvements in prefrontal hemodynamics and a reduction in ADHD symptoms.

Waitlist Available
Online Trial

The University of Texas at Austin

Have you considered Dexedrine clinical trials?

We made a collection of clinical trials featuring Dexedrine, we think they might fit your search criteria.
Go to Trials
Image of Louisiana State University in Baton Rouge, United States.

Virtual Reality for ADHD

18 - 25
All Sexes
Baton Rouge, LA

The goal of this larger parallel group randomized trial is to test the impact of a virtual reality program for improving the ability of emerging adults (age 18-25) with attention deficit hyperactivity disorder (ADHD) to stay focused while completing homework and studying. This study compares the impact of using a virtual reality headset to using a virtual reality headset while also receiving feedback about levels of focus to a control group. The main question is whether participants demonstrate significantly improved concentration while completing homework and studying in virtual reality and whether they enjoy and prefer working in a virtual reality environment. Concentration is measured both through participant report and also using keyboard and mouse click data to assess work productivity objectively.

Phase 4
Waitlist Available

Louisiana State University (+1 Sites)

Joshua M Langberg, PhD

Image of Duke University in Durham, United States.

Organizational Skills Training vs Mindfulness for ADHD

13 - 17
All Sexes
Durham, NC

This randomized control trial comparing Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) among adolescents with a pre-existing ADHD diagnosis presenting to the Duke ADHD Program. Both treatments are eight 90 minute sessions. The research component will involve a pre-treatment assessment and post-treatment assessment. Both assessments will involve adolescents and one caregiver to complete questionnaires over REDCap. Rating scales will include ADHD symptom severity (Conners 3: self and parent report), functional impairment (IRS: self and parent report), executive functioning (BRIEF-2: parent report), emotion dysregulation (DERS: self and parent report), trait mindfulness (FFMQ: self report), organizational skills (BRIEF-2: parent report), treatment satisfaction (self report and parent report) and credibility (self report and parent report). Post-treatment assessments for feasibility will include attendance (measured over the course of treatment) and homework completion rates on a scale of 1 to 5 in which 5 indicates higher homework completion. We will also assess acceptability via individual items on a Likert scale (self report): overall satisfaction, how much was learned about ADHD, usefulness of information learned, content relevance to individual experience, comprehension of strategies, confidence about using strategies, likelihood of using strategies, helpfulness to share with the group, benefits from hearing from other group members, willingness to recommend the same treatment to others, and whether or not treatment was beneficial.

Recruiting
Has No Placebo

Duke University

John Mitchell, PhD

Image of Kennedy Krieger Institute in Baltimore, United States.

Iron Supplementation for ADHD and Restless Sleep

8 - 18
All Sexes
Baltimore, MD

The goal of this clinical trial is to learn if iron supplementation works to restless sleep in youth with ADHD. A second goal is to learn if iron supplementation helps to ease ADHD symptoms. The main questions that this trial aims to answer are: Does 3 months of iron supplementation treatment improve parent- and youth self-reported sleep difficulties more than placebo? Does 3 months of iron supplementation treatment improve sleep as measured by actigraphy more than placebo? Does 3 months of iron supplementation treatment improve parent-reported and/or objectively measured attention more than placebo? Researchers will compare over-the-counter iron supplementation treatment to a placebo (a look-alike substance that contains no drug) to see if iron supplementation works to treat sleep difficulties in youth with ADHD. Participants will: * Take iron supplements every day for 3 months * Visit the clinic once before treatment begins and once at the end of treatment to complete tests and rating scales related to sleep and attention * Wear motion-monitoring leg bands while sleeping for one 2-week period before treatment begins and one 2-week period at the end of treatment

Phase 1 & 2
Waitlist Available

Kennedy Krieger Institute

Alison E Pritchard, PhD

Image of Montana State University in Bozeman, United States.

Speech-Gesture Combinations for Autism

Any Age
All Sexes
Bozeman, MT

This research study investigates how hand gestures can support language comprehension and communication skills of hearing speaking, non-speaking, and/or minimally verbal individuals with Autism Spectrum Disorders (ASD), who are especially disadvantaged by the lack of accessible services in their rural communities. Individuals with other cognitive profiles, including Developmental Language Disorder (DLD), ADHD, Dyslexia, and others are welcome too. The study uses methods of eye tracking and recording of brain activity to understand how hand gestures adapted from signs from American Sign Language, such as \[cry\], can promote successful understanding of words like "cry". The overarching goal is to help families effectively utilize gestures to support communication with their children.

Recruiting
Has No Placebo

Montana State University

Have you considered Dexedrine clinical trials?

We made a collection of clinical trials featuring Dexedrine, we think they might fit your search criteria.
Go to Trials